The FDA has ordered MacroGenics to halt enrollment in a phase 2 trial of the biotech’s lead candidate lorigerlimab following severe side effects that led to one patient's death.
A patient has died in a mid-stage study of MacroGenics’ bispecific antibody lorigerlimab in gynecologic cancers, prompting ...
A recent study revealed that adult patients with cancer who faced a new-onset mental health disorder are at a significantly ...
The FDA partially pauses cancer drug trial of lorigerlimab after four safety events, including one death, affecting enrollment in MacroGenics' phase ...
In a study of adults with cancer, those who developed a mental health condition within the first year after their cancer diagnosis had a higher likelihood of dying over the next few years. The ...
Dr. Karen Knudsen, CEO of the Parker Institute for Cancer Immunotherapy, told NewsNation too much groundbreaking cancer ...
About 20% of colorectal cancer cases are in those 54 and younger, according to a 2025 report. That rate is twice as high as it was in 1995.
In 2026, an estimated 158,850 new cases of colorectal cancer (CRC) will be diagnosed, and 55,230 people will die from the ...
Mental health linked to higher risk of death in cancer patients - Charities and researchers have called for mental health screening for people diagnosed with cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results